Richmond Pharmacology is excited to join the CRISPR Medicine Conference 2026 in Copenhagen, Denmark, on 14–16 April 2026.

This global conference brings together pioneers in gene editing, therapeutic development, and genome engineering to explore cutting‑edge CRISPR technologies and their translation into safe, effective clinical applications.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager
  • Tom Ashdown, Associate Medical Director

Our Focus at the Conference

  • Advances in CRISPR‑based therapeutics and delivery systems
  • Clinical translation of gene‑editing technologies
  • Regulatory and ethical considerations for genome‑editing trials
  • Safety assessment strategies for first‑in‑human and early‑phase CRISPR studies
  • Collaboration across industry, academia, and regulatory communities

Connect With Us

If you are attending the CRISPR Medicine Conference 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: The 3rd CRISPR Medicine Conference Copenhagen, April 14-16th, 2026, CRISPRMED26

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event